9th DIA Cell and Gene Therapy Products Symposium in Japan

Development of Next-Generation Cell and Gene Products - Issues in Development of Existing Products and Prospects for Practical Application of Next Generation Products -

戻る Agenda

Keynote Address 2 : Developing iPS Cell-Derived immunotherapy Products

Session Chair(s)

Ryutaro Hirasawa

CMC Regulatory Affairs, Associate Director

Daiichi Sankyo Co., Ltd., Japan

Speaker(s)

Shin Kaneko, MD, PhD

Kyoto University, Japan

Dept of Cell Growth and Differentiation, CiRA